SCHEMBL1989780

SCHEMBL1989780

O=C(O)OC1CC(O)CN1

nearest known ligand 0.31

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 4/20 0.31
DPP8 Q6V1X1 4/20 0.31
DPP9 Q86TI2 4/20 0.31
CYP1A2 P05177 1/20 0.30
CYP2D6 P10635 1/20 0.30
ALOX15 P16050 1/20 0.30
CYP2C19 P33261 1/20 0.30
SLC1A3 P43003 1/20 0.30
SLC1A2 P43004 1/20 0.30
SLC1A1 P43005 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2558329 1.00 DPP4 (0.31) DPP4DPP8DPP9CYP1A2CYP2D6
SCHEMBL2562325 1.00 DPP4 (0.31) DPP4DPP8DPP9CYP1A2CYP2D6
SCHEMBL5594839 0.83
SCHEMBL10753923 0.81
SCHEMBL27835327 0.81 CHRM2 (0.33) DPP4DPP8DPP9CYP2D6CYP2C19
Hydrochloric Acid SCHEMBL27763502 0.79 CHRM2 (0.33) CYP2D6CYP2C19
Hydrochloric Acid SCHEMBL4427864 0.79 CHRM2 (0.33) CYP2D6CYP2C19
SCHEMBL542356 0.78 CYP1A2 (0.30) CYP1A2CYP2D6ALOX15CYP2C19SLC1A3
SCHEMBL2462437 0.78 CHRNB2 (0.32)
SCHEMBL5719553 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2651516-B1 DYE COMPOSITION COMPRISING A HETEROCYCLIC OXIDATION BASE AND A 4-AMINOINDOLE COUPLER L'ORÉAL (FR) 2017-06-14 EP claimed
EP-1312606-B1 2,5-diaminopyridine oxidation bases and their use for dyeing of keratin fibres OREAL (FR) 2011-09-21 EP claimed
EP-1764082-B1 4-5-diamino-N,N-dihydro-pyrazol-3-one derivatives for use in composition for dyeing keratin fibres OREAL (FR) 2011-06-29 EP claimed
JP-4705015-B2 2011-06-22 JP claimed
EP-1733713-B1 Composition for dyeing keratinic fibres comprising a diamino-N,N-dihydro-pyrazolone dervative, a coupling agent and a selected surface-active agent OREAL (FR) 2010-06-02 EP claimed
EP-1733714-B1 Composition for dyeing keratinic fibres comprising a diamino-N,N-dihydro-pyrazolone derivative, a coupling agent and a polyol OREAL (FR) 2010-05-19 EP claimed
EP-1733716-B1 Composition for dyeing keratin fibres comprising a diamino-N,N-dihydro-pyrazolone derivative, a coupling agent and an associative polyurethane polymer OREAL (FR) 2010-05-19 EP claimed
EP-1733715-B1 Composition for dyeing keratinic fibres comprising a diamino-N,N-dihydro-pyrazolone derivative, a coupling agent and a heterocyclic direct dye OREAL (FR) 2010-01-27 EP claimed
EP-1728500-B1 Composition for dyeing keratinic fibres comprising a diamino-N,N-dihydro-pyrazolon derivative and a cationic oxidation dye OREAL (FR) 2010-01-27 EP claimed
EP-1728499-B1 Composition for dyeing keratinic fibres comprising a diamino-N,N-dihydro-pyrazolone derivative and a 2,3-diaminopyridine coupler OREAL (FR) 2010-01-06 EP claimed
EP-1550656-B1 fused 4-5-diamino-n,n-dihydro-pyrazol-3-one derivatives for use in composition for dyeing keratin fibres OREAL (FR) 2009-05-06 EP claimed
EP-1720844-A2 PYRROLIDINO-1,2-DICARBOXY-1-(PHENYLAMIDE)-2-(4-(3-OXO-MORPHOLINO-4-YL)-PHENYLAMIDE) DERIVATIVES AND RELATED COMPOUNDS FOR USE AS INHIBITORS OF COAGULATION FACTOR XA IN THE TREATMENT OF THROMBO-EMBOLIC DISEASES MERCK PATENT GmbH (DE) 2006-11-15 EP claimed
JP-2006522033-A 2006-09-28 JP claimed
WO-2004087646-A2 PYRROLIDINO-1,2-DICARBOXY-1-(PHENYLAMIDE)-2-(4-(3-OXO-MORPHOLINO-4-YL)-PHENYLAMIDE) DERIVATIVES AND RELATED COMPOUNDS FOR USE AS INHIBITORS OF COAGULATION FACTOR XA IN THE TREATMENT OF THROMBO-EMBOLIC DISEASES MERCK PATENT GMBH (DE) 2004-10-14 WO claimed
EP-0564972-A2 Peptides with N-terminal modifications having bradykinin antagonistic activity HOECHST AKTIENGESELLSCHAFT (DE) 1993-10-13 EP claimed
EP-0740938-A2 Proline and 4-hydroxyproline as therapeutic agents IPR-Institute for Pharmaceutical Research Riehen AG (CH) 1996-11-06 EP disclosed
EP-0564972-A2 Peptides with N-terminal modifications having bradykinin antagonistic activity HOECHST AKTIENGESELLSCHAFT (DE) 1993-10-13 EP disclosed